OTR Global downgrades Generac Hldgs (NYSE:GNRC) from Mixed to Negative.
Why This Small-Cap Stock Is Gaining More Than 10% Today?
Chardan has initiated coverage of Immuneering Corp (NASDAQ:IMRX) with a Buy rating and a price target of $18. Immuneering’s lead candidate, IMM-1-104, an…